These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2829603)

  • 1. Chronic lymphocytic leukaemia with raised serum IgM levels.
    Ukaejiofo EO; Onwukeme KE; Sagoe AS; Esan GJ
    Afr J Med Med Sci; 1987 Sep; 16(3):113-8. PubMed ID: 2829603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenomegaly in Northern Nigeria.
    Bryceson AD; Fleming AF; Edington GM
    Acta Trop; 1976; 33(3):185-214. PubMed ID: 11654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tropical splenomegaly syndrome or chronic lymphatic leukaemia?
    Fakunle YM; Greenwood BM; Fleming AF; Danon F
    Trop Geogr Med; 1979 Sep; 31(3):353-8. PubMed ID: 524446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of lymphocyte transformation and IgM estimation as diagnostic aids in leukaemoid reactions.
    Ukaejiofo EO; David-West AS
    J Trop Med Hyg; 1979; 82(9-10):197-200. PubMed ID: 529352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological identification of peripheral-blood lymphocytes from patients with lymphoproliferative disorders in Nigeria. II. Chronic lymphocytic leukaemia (CLL).
    Ukaejiofo EO; Sagoe AS; Osunkoya BO
    Afr J Med Med Sci; 1983; 12(3-4):197-202. PubMed ID: 6326554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tropical splenomegaly syndrome in Nigerian adults.
    Onuigbo MA; Mbah AU
    West Afr J Med; 1992; 11(1):72-8. PubMed ID: 1637745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobin M and malarial antibody levels in hyper-reactive malarial splenomegaly.
    De Cock KM; Hodgen AN; Jupp RA; Slavin B; Siongok TK; Rees PH; Lucas SB
    J Trop Med Hyg; 1986 Jun; 89(3):119-21. PubMed ID: 3773024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surface immunoglobulins of lymphocytes in chronic lymphocytic leukemia].
    Leszko B; Litwin J; Sylwestrowicz T; Pawelski S
    Acta Haematol Pol; 1976; 7(1):23-30. PubMed ID: 1251673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of circulating immune complexes in patients with chronic lymphocytic leukaemia. Correlations between clinical and immunological features.
    Mozzana R; Baldini L; Neri A; Cortelezzi A; Radaelli F; Colajori E; Polli EE
    Boll Ist Sieroter Milan; 1982; 61(4):324-9. PubMed ID: 6927220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
    Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
    Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM.
    Qian GX; Fu SM; Solanki DL; Rai KR
    J Immunol; 1984 Dec; 133(6):3396-400. PubMed ID: 6333459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biclonal IgM gammopathy in chronic lymphocytic leukemia.
    Schaffner KF; Krause JR; Kelly RH
    Arch Pathol Lab Med; 1988 Feb; 112(2):206-8. PubMed ID: 3122707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of suppressor T lymphocytes in the tropical splenomegaly syndrome.
    Hoffman SL; Piessens WF; Ratiwayanto S; Hussein PR; Kurniawan L; Piessens PW; Campbell JR; Marwoto HA
    N Engl J Med; 1984 Feb; 310(6):337-41. PubMed ID: 6228739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogen-stimulated immunoglobulin production by chronic lymphocytic leukaemic lymphocytes.
    Johnstone AP; Jensenius JC; Millard RE; Hudson L
    Clin Exp Immunol; 1982 Mar; 47(3):697-705. PubMed ID: 6805990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight (7S) IgM and free light chains in the sera of patients with the tropical splenomegaly syndrome.
    Fakunle YM; Greenwood BM
    Clin Exp Immunol; 1977 Apr; 28(1):153-6. PubMed ID: 405168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
    Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
    Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group.
    Melo JV; Catovsky D; Galton DA
    Br J Haematol; 1986 Jun; 63(2):377-87. PubMed ID: 3487341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some biological and epidemiological characteristics of human leukaemia in Africans.
    Williams CK
    IARC Sci Publ; 1984; (63):687-712. PubMed ID: 6598802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lycurim (R-74) in the therapy of chronic lymphocytic leukaemia.
    Vygovskaya YI; Loginsky VE; Vorobel AV; Kondratieva NA; Mazurok AA; Korotky VV; Kotsay BR
    Haematologia (Budap); 1981 Dec; 14(4):399-405. PubMed ID: 6178656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface localized IgM-kappa immunoglobulin reactivity in a case of chronic lymphocytic leukaemia.
    Johansson B; Klein E
    Clin Exp Immunol; 1970 Mar; 6(3):421-8. PubMed ID: 4191826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.